Sort
40,608 grants matching “prostate cancer”
PSMAâs enzymatic activity as new target for Prostate Cancer diagnosis and therapy
$719,857Jan Grimm · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Clinical Qualification of Imaging and Fluid-Based Tumor Monitoring Biomarkers for Metastatic Castration Resistant Prostate Cancer
$719,712Lawrence H Schwartz · Columbia University Health Sciences · R01 · FY2020 · CA
Discovery and characterization of clinically actionable germline mutations in DNA damage repair (DDR) pathway genes in lung cancer
$719,691Semanti Mukherjee · Sloan-Kettering Inst Can Research · R37 · FY2022 · CA
Exosomal Drug Delivery
$719,680Wendy A Spencer · 3p Biotechnologies, Inc. · R44 · FY2017 · CA
Cooperative Human Tissue Network Support through Duke's BioRepository & Precision Pathology Center
$719,670Shannon Jones McCall · Duke University · UM1 · FY2025 · CA
Cooperative Human Tissue Network Support through Duke's BioRepository & Precision Pathology Center
$719,670Shannon Jones McCall · Duke University · UM1 · FY2024 · CA
Clinical Pharmacogenetics
$719,430William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
SINGLE CELL CHARACTERIZATION OF PROSTATE CANCER-CIRCULATING TUMOR CELLS
$719,231The Leland Stanford Junior University · · FY2010 · Department of the Army
Developing Informatics Technologies to Model Cancer Gene Regulation
$718,986Clifford Meyer · Dana-Farber Cancer Inst · U24 · FY2023 · CA
Promoting Equity of Cancer Screening and Follow-up for Lung Cancer
$718,974Chyke Abadama Doubeni · Ohio State University · R01 · FY2023 · CA
Optimizing Lung Cancer Screening in Cancer Survivors
$718,813Juan P Wisnivesky · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA
Development/Clinical Validation Markers for Prostate Ca
$718,527Alan W Partin · Johns Hopkins University · U01 · FY2009 · CA
NSAIDS and Other Medications in Prostate Cancer Etiology
$718,429Fred Hutchinson Cancer Research Center · R01 · FY2004 · CA
Energy Balance-Related Hormones & Prostate Cancer Incidence & Progression
$717,954Edward Giovannucci · Harvard School Of Public Health · R01 · FY2008 · CA
Artificial intelligence enabled Stroma-Weighted Automated Grading system to improve risk stratification in Black Men
$717,667Ashutosh K Tewari · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
High Energy and Spatial Resolution Multi-Isotope SPECT Imaging of Targeted Alpha-Emitters and their Daughters
$717,441George Sgouros · Johns Hopkins University · U01 · FY2022 · EB
Nuclear Factor-kappaB in Ovarian Cancer
$717,308Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
TARGETING PROSTATE CANCER CELLS BY COMBINED OXIDATIVE STRESS INDUCTION AND ANDROGEN RECEPTOR ANTAGONISM
$716,867Wayne State University · · FY2012 · Department of the Army
The Prostate Cancer Tumor Microenvironment Exhibits Differentially Expressed Gene
$716,818Dan Mercola · University Of California-Irvine · U01 · FY2013 · CA
DNA repair gene mutations and prostate cancer
$716,750Binghui Shen · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA
RACIAL DISPARITIES IN PALLIATIVE CARE FOR PROSTATE CANCER
$716,722The Trustees Of Columbia University In The City Of New York · · FY2010 · Department of Defense
Cardiovascular Risk Prediction and Reduction in Men with Prostate Cancer
$716,697Bonnie Ky · University Of Pennsylvania · R01 · FY2025 · HL
Molecular Determinants of Social Factors in Prostate Cancer
$716,675Deepak Kumar · North Carolina Central University · R01 · FY2019 · MD
Carolina Community Network Center to Reduce Cancer Health Disparities (CCN II)
$716,673Paul A. Godley · Univ Of North Carolina Chapel Hill · U54 · FY2012 · CA
Addressing racial disparities in colorectal cancer risk prediction
$716,672Kerrie P Nelson · Boston University Medical Campus · R01 · FY2024 · CA